Lipids and prostate cancer adenocarcinoma

被引:3
作者
Alioui, Anthony [1 ,2 ,3 ,4 ]
Celhay, Olivier [1 ,2 ,3 ,4 ,5 ]
Baron, Silvere [1 ,2 ,3 ,4 ]
Lobaccaro, Jean-Marc A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Clermont Ferrand, Clermont Univ, F-63000 Clermont Ferrand, France
[2] CNRS, UMR 6293, GReD, F-63171 Aubiere, France
[3] INSERM, UMR 6293, GReD, F-63171 Aubiere, France
[4] Ctr Rech Nutr Humaine Auvergne, F-63000 Clermont Ferrand, France
[5] CHU Clermont Ferrand, Serv Urol, F-63000 Clermont Ferrand, France
关键词
cholesterol; lipids; liver X receptors; prostate cancer; SLiMs; LIVER-X-RECEPTOR; STEROL REGULATORY ELEMENT; DENSITY-LIPOPROTEIN RECEPTOR; CELL SIGNALING PATHWAYS; LIGAND-BINDING DOMAIN; HMG-COA REDUCTASE; ANDROGEN RECEPTOR; CHOLESTEROL-METABOLISM; FEEDBACK-REGULATION; NUCLEAR RECEPTOR;
D O I
10.2217/CLP.14.51
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Due to their amphiphilic properties, lipids are able to form various biological structures through the development of specific vesicles. Fatty acids and cholesterol thus constitute important molecules for lipid membrane composition. Conversely lipid dysfunction, and more specifically cholesterol homeostasis dysregulation, is involved in a wide range of pathologies. Among these, cancerous lesions have been correlated with cholesterol accumulation. However, links between cholesterol and cancer promotion and progression are still poorly understood and characterized although it is now assumed that sensing and controlling cholesterol levels may be critical for cancer kinetics. This review will focus on lipid abnormalities associated with prostate cancer adenocarcinoma, as well as the mechanisms by which cholesterol may promote cancer progression. Pharmacologically, molecules inhibiting HMG-CoA reductase or activating liver X receptors, the nuclear receptors for oxysterols, could disrupt cholesterol contribution to prostate carcinogenesis.
引用
收藏
页码:643 / 655
页数:13
相关论文
共 110 条
  • [1] Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost-effectiveness
    Akaza, Hideyuki
    [J]. CANCER SCIENCE, 2011, 102 (01) : 51 - 56
  • [2] Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
    Alberti, S
    Schuster, G
    Parini, P
    Feltkamp, D
    Diczfalusy, U
    Rudling, M
    Angelin, B
    Björkhem, I
    Pettersson, S
    Gustafsson, JÅ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05) : 565 - 573
  • [3] DISCOVERY, BIOCHEMISTRY AND BIOLOGY OF LOVASTATIN
    ALBERTS, AW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (15) : J10 - J15
  • [4] Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis
    Alonso, DF
    Farina, HG
    Skilton, G
    Gabri, MR
    De Lorenzo, MS
    Gomez, DE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 50 (01) : 83 - 93
  • [5] Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression
    Azoulay, S.
    Terry, S.
    Chimingqi, M.
    Sirab, N.
    Faucon, H.
    de Medina, S. Gil Diez
    Moutereau, S.
    Maille, P.
    Soyeux, P.
    Abbou, C.
    Salomon, L.
    Vacherot, F.
    de la Taille, A.
    Loric, S.
    Allory, Y.
    [J]. JOURNAL OF PATHOLOGY, 2008, 216 (04) : 460 - 470
  • [6] Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study
    Batty, G. David
    Kivimaeki, Mika
    Clarke, Robert
    Smith, George Davey
    Shipley, Martin J.
    [J]. CANCER CAUSES & CONTROL, 2011, 22 (02) : 311 - 318
  • [7] BIOLOGICAL SYNTHESIS OF CHOLESTEROL
    BLOCH, K
    [J]. SCIENCE, 1965, 150 (3692) : 19 - &
  • [8] STEROL MOLECULE - STRUCTURE, BIOSYNTHESIS, AND FUNCTION
    BLOCH, K
    [J]. STEROIDS, 1992, 57 (08) : 378 - 383
  • [9] Statin use and cancer risk: a comprehensive review
    Boudreau, Denise M.
    Yu, Onchee
    Johnson, Jeanene
    [J]. EXPERT OPINION ON DRUG SAFETY, 2010, 9 (04) : 603 - 621
  • [10] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340